Christopher Hocking
About
In The Last Decade
Christopher Hocking
16 papers receiving 329 citations
Hit Papers
Peers
Comparison fields: 5 of 52
- Pulmonary and Respiratory Medicine 186
- Oncology 173
- Molecular Biology 107
- Cancer Research 86
- Surgery 85
Countries citing papers authored by Christopher Hocking
This map shows the geographic impact of Christopher Hocking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Hocking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Hocking more than expected).
Fields of papers citing papers by Christopher Hocking
This network shows the impact of papers produced by Christopher Hocking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Hocking. The network helps show where Christopher Hocking may publish in the future.
Co-authorship network of co-authors of Christopher Hocking
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Hocking. A scholar is included among the top collaborators of Christopher Hocking based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Hocking. Christopher Hocking is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial breakdown → | 177 |
| 4 | 2 | |
| 5 | 16 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 55 | |
| 9 | 1 | |
| 10 | 9 | |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 28 | |
| 14 | 3 | |
| 15 | 8 | |
| 16 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.